AU2012320674A1 - Template -fixed peptidomimetics as inhibitors of FPR1 - Google Patents

Template -fixed peptidomimetics as inhibitors of FPR1 Download PDF

Info

Publication number
AU2012320674A1
AU2012320674A1 AU2012320674A AU2012320674A AU2012320674A1 AU 2012320674 A1 AU2012320674 A1 AU 2012320674A1 AU 2012320674 A AU2012320674 A AU 2012320674A AU 2012320674 A AU2012320674 A AU 2012320674A AU 2012320674 A1 AU2012320674 A1 AU 2012320674A1
Authority
AU
Australia
Prior art keywords
tyr
cys
trp
pro
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012320674A
Other languages
English (en)
Inventor
Eric Chevalier
Francoise Jung
Guillaume Lemercier
Ralf Lowe
Daniel Obrecht
Johann Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spexis AG
Original Assignee
Polyphor AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor AG filed Critical Polyphor AG
Publication of AU2012320674A1 publication Critical patent/AU2012320674A1/en
Priority to AU2017204122A priority Critical patent/AU2017204122B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2012320674A 2011-10-07 2012-10-02 Template -fixed peptidomimetics as inhibitors of FPR1 Abandoned AU2012320674A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017204122A AU2017204122B2 (en) 2011-10-07 2017-06-19 Template -fixed peptidomimetics as inhibitors of FPR1

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11008121 2011-10-07
EP11008121.3 2011-10-07
PCT/EP2012/069412 WO2013050346A1 (en) 2011-10-07 2012-10-02 Template -fixed peptidomimetics as inhibitors of fpr1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017204122A Division AU2017204122B2 (en) 2011-10-07 2017-06-19 Template -fixed peptidomimetics as inhibitors of FPR1

Publications (1)

Publication Number Publication Date
AU2012320674A1 true AU2012320674A1 (en) 2014-03-20

Family

ID=46970289

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2012320674A Abandoned AU2012320674A1 (en) 2011-10-07 2012-10-02 Template -fixed peptidomimetics as inhibitors of FPR1
AU2017204122A Ceased AU2017204122B2 (en) 2011-10-07 2017-06-19 Template -fixed peptidomimetics as inhibitors of FPR1

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2017204122A Ceased AU2017204122B2 (en) 2011-10-07 2017-06-19 Template -fixed peptidomimetics as inhibitors of FPR1

Country Status (11)

Country Link
US (1) US9957297B2 (enExample)
EP (1) EP2764010B9 (enExample)
JP (1) JP6294227B2 (enExample)
CN (1) CN103842373B (enExample)
AU (2) AU2012320674A1 (enExample)
CA (1) CA2848584C (enExample)
ES (1) ES2576959T3 (enExample)
IL (1) IL231756B (enExample)
MX (1) MX349788B (enExample)
SG (1) SG11201400354PA (enExample)
WO (1) WO2013050346A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009008843A (es) 2007-02-28 2009-08-28 Polyphor Ltd Peptidomimeticos fijados a un patron.
US10654897B2 (en) * 2014-09-30 2020-05-19 Polyphor Ag β-hairpin peptidomimetics
US10259847B2 (en) 2014-09-30 2019-04-16 Polyphor Ag Beta-hairpin peptidomimetics
US10829520B2 (en) * 2015-03-23 2020-11-10 Polyphor Ag Beta-hairpin peptidomimetics
CA3032885C (en) * 2016-09-06 2023-06-20 Mainline Biosciences Cxcr4 antagonists and methods of use
CN112094316B (zh) * 2017-06-29 2022-04-08 安徽省农业科学院农产品加工研究所 一种Ser和Cys分列在两端的高锌螯合活性锌鳌合肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253146B2 (en) 2001-02-23 2007-08-07 Polyphor Ltd Template-fixed peptidomimetics with antimicrobial activity
AU2002342618C1 (en) * 2002-08-20 2008-10-30 Polyphor Ltd. Template-fixed peptidomimetics with antibacterial activity
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
US7671028B2 (en) * 2004-02-04 2010-03-02 Postech Foundation Peptides that antagonize FPR class receptor mediated signaling
EP1879911B1 (en) 2005-05-02 2011-08-17 Polyphor Ltd. Dye conjugates of template-fixed peptidomimetics
MX2009008843A (es) * 2007-02-28 2009-08-28 Polyphor Ltd Peptidomimeticos fijados a un patron.
US8883720B2 (en) 2008-11-26 2014-11-11 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
US8865656B2 (en) * 2009-05-07 2014-10-21 Polyphor Ag Beta-hairpin peptidomimetics having CXCR4 antagonizing activity
EP2438047B1 (en) * 2009-06-02 2014-07-30 Nikan Pharmaceuticals, LLC Antagonism of human formyl peptide receptor for treatment of disease
WO2011066869A1 (en) * 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics

Also Published As

Publication number Publication date
CA2848584A1 (en) 2013-04-11
CA2848584C (en) 2020-03-24
CN103842373B (zh) 2018-12-21
AU2017204122A1 (en) 2017-07-06
JP2014528958A (ja) 2014-10-30
EP2764010B1 (en) 2016-03-16
MX2014003960A (es) 2014-05-14
JP6294227B2 (ja) 2018-03-14
IL231756A0 (en) 2014-05-28
US9957297B2 (en) 2018-05-01
MX349788B (es) 2017-08-11
CN103842373A (zh) 2014-06-04
EP2764010A1 (en) 2014-08-13
IL231756B (en) 2019-06-30
ES2576959T9 (es) 2017-05-29
EP2764010B9 (en) 2017-01-18
ES2576959T3 (es) 2016-07-12
WO2013050346A1 (en) 2013-04-11
NZ621974A (en) 2015-06-26
SG11201400354PA (en) 2014-09-26
AU2017204122B2 (en) 2019-05-02
US20140287986A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
US9637520B2 (en) Template-fixed peptidomimetics with CXCR7 modulating activity
AU2017204122B2 (en) Template -fixed peptidomimetics as inhibitors of FPR1
CN102712676B (zh) 具有ccr10 拮抗活性的模板固定的拟肽
US10370411B2 (en) Beta-hairpin peptidomimetics
US10370412B2 (en) Beta-hairpin peptidomimetics
JP2017534600A (ja) ベータ−ヘアピンペプチド模倣体
US10259847B2 (en) Beta-hairpin peptidomimetics
HK1193831B (en) Template-fixed peptidomimetics as inhibitors of fpr1
HK1193831A (en) Template-fixed peptidomimetics as inhibitors of fpr1
NZ621974B2 (en) Template-fixed peptidomimetics as inhibitors of fpr1
HK1240952A1 (en) Beta-hairpin peptidomimetics
HK1240949A1 (en) Beta-hairpin peptidomimetics
HK1225399B (en) Beta-hairpin peptidomimetics
EP2501715A1 (en) Template-fixed peptidomimetics with ccr10 antagonistic activty

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted